Logo image of ALEX.CA

ALPHA EXPLORATION LTD (ALEX.CA) Stock Fundamental Analysis

TSX-V:ALEX - TSX Venture Exchange - VGG3198S1074 - Common Stock - Currency: CAD

0.68  -0.01 (-1.45%)

Fundamental Rating

2

ALEX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. While ALEX has a great health rating, there are worries on its profitability. ALEX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALEX had negative earnings in the past year.
ALEX had a negative operating cash flow in the past year.
ALEX.CA Yearly Net Income VS EBIT VS OCF VS FCFALEX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.30%, ALEX is in the better half of the industry, outperforming 79.24% of the companies in the same industry.
ALEX has a Return On Equity of -2.53%. This is amongst the best in the industry. ALEX outperforms 80.19% of its industry peers.
Industry RankSector Rank
ROA -2.3%
ROE -2.53%
ROIC N/A
ROA(3y)-5.9%
ROA(5y)N/A
ROE(3y)-6.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEX.CA Yearly ROA, ROE, ROICALEX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALEX.CA Yearly Profit, Operating, Gross MarginsALEX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for ALEX has been increased compared to 1 year ago.
ALEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALEX.CA Yearly Shares OutstandingALEX.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
ALEX.CA Yearly Total Debt VS Total AssetsALEX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 18.19 indicates that ALEX is not in any danger for bankruptcy at the moment.
ALEX has a better Altman-Z score (18.19) than 79.78% of its industry peers.
ALEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.19
ROIC/WACCN/A
WACCN/A
ALEX.CA Yearly LT Debt VS Equity VS FCFALEX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

ALEX has a Current Ratio of 2.11. This indicates that ALEX is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.11, ALEX perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
ALEX has a Quick Ratio of 2.11. This indicates that ALEX is financially healthy and has no problem in meeting its short term obligations.
ALEX has a Quick ratio of 2.11. This is comparable to the rest of the industry: ALEX outperforms 54.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ALEX.CA Yearly Current Assets VS Current LiabilitesALEX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

ALEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.15%, which is quite impressive.
EPS 1Y (TTM)87.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEX.CA Yearly Revenue VS EstimatesALEX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
ALEX.CA Yearly EPS VS EstimatesALEX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEX.CA Price Earnings VS Forward Price EarningsALEX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALEX.CA Per share dataALEX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHA EXPLORATION LTD

TSX-V:ALEX (3/7/2025, 7:00:00 PM)

0.68

-0.01 (-1.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-22 2024-05-22
Earnings (Next)N/A N/A
Inst Owners10.71%
Inst Owner ChangeN/A
Ins Owners11.72%
Ins Owner ChangeN/A
Market Cap61.65M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.74
P/tB 2.74
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.25
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.3%
ROE -2.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.9%
ROA(5y)N/A
ROE(3y)-6.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 18.19
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.6%
OCF growth 3YN/A
OCF growth 5YN/A